Since ALK overexpression is associated with neuroendocrine (NE) differentiation and TP53 gene status in ovarian high-grade serous carcinomas and uterine carcinosarcoma [18, 19], we investigated NE markers and p53 staining in Em Ca. This evidence concerns the gene ALK and serous adenocarcinoma.